Thorac Cardiovasc Surg 2019; 67(03): 212-215
DOI: 10.1055/s-0038-1642066
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS

Desiree A. Steimer
1   Department of Thoracic Surgery and Lung Transplantation, Baylor University Medical Center, Dallas, Texas, United States
,
Omar Hernandez
1   Department of Thoracic Surgery and Lung Transplantation, Baylor University Medical Center, Dallas, Texas, United States
,
David P. Mason
1   Department of Thoracic Surgery and Lung Transplantation, Baylor University Medical Center, Dallas, Texas, United States
,
Gary S. Schwartz
1   Department of Thoracic Surgery and Lung Transplantation, Baylor University Medical Center, Dallas, Texas, United States
› Author Affiliations
Further Information

Publication History

13 December 2017

05 March 2018

Publication Date:
01 May 2018 (online)

Abstract

In the past decade, extracorporeal membrane oxygenation (ECMO) has emerged as an innovative therapy for influenza-associated acute respiratory distress syndrome (ARDS). Despite its promising results, the ideal timing of ECMO initiation for these patients remains unclear. Retrospective analysis of a single institution experience with venovenous ECMO for influenza-induced ARDS was performed. Twenty-one patients were identified and categorized into early (0–2 days), standard (3–6 days), or late (more than 7 days) cannulation cohorts. Patients cannulated within 48 hours of admission had 80% survival rate at 90 days. Comparatively, the standard and late cannulation cohorts had an observed 90-day survival rate of 60 and 16.7%, respectively.

Note

This study was presented at the American Association for Thoracic Surgery Centennial Meeting in Boston, MA; April 29–May 3, 2017.